Location History:
- Bethesda, MD (US) (2020 - 2024)
- Aurora, CO (US) (2022 - 2024)
Company Filing History:
Years Active: 2020-2025
Title: Innovations of Terry J Fry
Introduction
Terry J Fry is a notable inventor based in Bethesda, MD, who has made significant contributions to the field of biomedical research. He holds a total of 9 patents, showcasing his innovative work in developing therapies for cancer treatment.
Latest Patents
Among his latest patents is the invention of FLT3-specific chimeric antigen receptors and methods using the same. This invention provides a chimeric antigen receptor (CAR) that includes an antigen binding domain specific for FLT3, a transmembrane domain, and an intracellular T cell signaling domain. The patent also discloses nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions related to the CARs. Additionally, methods for detecting the presence of proliferative disorders, such as cancer, in mammals, as well as methods for treating or preventing these disorders, are included. Another significant patent describes human monoclonal antibodies that specifically bind to Fms-like tyrosine kinase 3 (FLT3). This patent outlines chimeric antigen receptors (CARs) and other antibody conjugates that incorporate the FLT3-specific monoclonal antibodies. Furthermore, it details methods for diagnosing and treating FLT3-associated cancers, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
Career Highlights
Terry J Fry is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to focus on groundbreaking research that has the potential to impact cancer treatment significantly.
Collaborations
Some of his notable coworkers include Haiying Qin and Christopher D Chien, who have collaborated with him on various research projects.
Conclusion
Terry J Fry's innovative contributions to cancer research through his patents and work at the National Institutes of Health highlight his commitment to advancing medical science. His inventions have the potential to improve treatment options for patients suffering from various forms of cancer.